ClosedPublished 2 Sep 2025

CorMedix Inc. /
Melinta Therapeutics, LLC

CorMedix Completes Merger With Melinta Therapeutics

Buy side: CorMedix Inc.
Buy sideCorMedix Inc.
Target: Melinta Therapeutics, LLC
TargetMelinta Therapeutics, LLC
CorMedix Inc. · 2 Sep 2025Source
Buy side: CorMedix Inc.
Buy sideCorMedix Inc.
Target: Melinta Therapeutics, LLC
TargetMelinta Therapeutics, LLC
01 / BuyerCorMedix Inc.
02 / TargetMelinta Therapeutics, LLC
Source for the buyer and target: CorMedix Inc.

For the buyer and target.

“On August 29, 2025 (the “Closing Date”), CorMedix Inc., a Delaware corporation (the “Company,” “CorMedix,” “we,” “our” and “us”) completed its previously announced merger with Melinta Therapeutics, LLC, a Delaware limited liability company (“Melinta”).”

Published 2 Sep 2025

Open the source
01

What happened

CorMedix Inc. completed its merger with Melinta Therapeutics, LLC on Aug. 29, 2025. Melinta survived the merger as a wholly owned subsidiary of CorMedix Inc. [01]

CorMedix paid Melinta equityholders $260 million in cash and $40 million worth of common shares. Contingent payments may also be made under the merger terms. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · CorMedix Inc.

CorMedix Completes Merger With Melinta Therapeutics

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    “CorMedix Completes Merger With Melinta Therapeutics CorMedix Inc. completed its merger with Melinta Therapeutics, LLC on Aug. 29, 2025”

    Open the source
  2. Published by CorMedix Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.